Please note this application is under active development. If you spot any errors or something isn't working, please contact us at evidence.service@wales.nhs.uk.

Interventions for smoking cessation in people diagnosed with lung cancer

Zeng L et al (2019)

Cochrane Database of Systematic Reviews - 10.1002/14651858.CD011751.pub3.

Evidence Categories

  • Care setting: Not described
  • Population group: Pre existing health condition
  • Intervention: Bupropian
  • Intervention: Multicomponent Interventions
  • Intervention: Behaviour Support
  • Intervention: Nicotine Replacement Therapy
  • Intervention: Varenicline
  • Outcome: Smoking cessation

Type of Evidence

Systematic Review

Aims

To determine the effectiveness of smoking cessation programmes for people with lung cancer.

Findings

The authors identified no RCTs that met our inclusion criteria. Among the 1817 records retrieved using the search strategy, they retrieved 19 studies for further investigation. The authors excluded 15 trials: ten trials because they could not distinguish people with lung cancer from the other participants, or the participants were not people with lung cancer, four because they were not randomised, or RCTs. The authors excluded one trial because, though it was completed in 2004, no results are available. They assessed four ongoing trials for inclusion when data becomes available."

Conclusions

There were no RCTs that determined the effectiveness of any type of smoking cessation programme for people with lung cancer. There was insufficient evidence to determine whether smoking cessation interventions are effective for people with lung cancer and whether one programme is more effective than any other. People with lung cancer should be encouraged to quit smoking and offered smoking cessation interventions. However, due to the lack of RCTs, the efficacy of smoking cessation interventions for people with lung cancer cannot be evaluated and concluded. This systematic review identified a need for RCTs to explore these.